Nuclear membrane proteins with potential disease links found by subtractive proteomics, Science, vol.301, issue.5638, p.12958361, 2003. ,
Several novel nuclear envelope transmembrane proteins identified in skeletal muscle have cytoskeletal associations, Mol Cell Proteomics, vol.10, issue.1, p.20876400, 2011. ,
The leukocyte nuclear envelope proteome varies with cell activation and contains novel transmembrane proteins that affect genome architecture, Mol Cell Proteomics, vol.9, issue.12, p.20693407, 2010. ,
The nuclear envelope at a glance, J Cell Sci, vol.123, p.20519579, 2010. ,
Pushing the envelope: structure, function, and dynamics of the nuclear periphery, Annu Rev Cell Dev Biol, vol.21, p.16212499, 2005. ,
Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy, Nat Genet, vol.8, issue.4, p.7894480, 1994. ,
Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy, Nat Genet, vol.12, issue.3, p.8589715, 1996. ,
X-linked form of Emery-Dreifuss muscular dystrophy, Acta Myol, vol.24, issue.2, p.16550925, 2005. ,
Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy, Nat Genet, vol.21, issue.3, p.10080180, 1999. ,
Emery-Dreifuss muscular dystrophy-a 40 year retrospective, Neuromuscul Disord, vol.10, issue.4-5, p.10838246, 2000. ,
Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan, Acta Myol, vol.26, issue.3, p.18646565, 2007. ,
Limb-girdle muscular dystrophy due to emerin gene mutations, Arch Neurol, vol.64, issue.7, p.17620497, 2007. ,
Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies, Handb Clin Neurol, vol.113, p.23622360, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00826557
Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles, Am J Pathol, vol.168, issue.3, p.16507906, 2006. ,
Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration, Hum Mol Genet, vol.15, issue.4, p.16403804, 2006. ,
Severe dystonia, cerebellar atrophy, and cardiomyopathy likely caused by a missense mutation in TOR1AIP1, Orphanet J Rare Dis, vol.9, p.25425325, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01110718
Mutation in TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: a novel gene related to nuclear envelopathies, Neuromuscul Disord, vol.24, issue.7, p.24856141, 2014. ,
Integral membrane proteins specific to the inner nuclear membrane and associated with the nuclear lamina, J Cell Biol, vol.107, issue.6, pp.2029-2065, 1988. ,
Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene, Ann Neurol, vol.48, issue.2, p.10939567, 2000. ,
Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies, Hum Mol Genet, vol.14, issue.1, p.15548545, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00165763
Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy, J Cell Biol, vol.147, issue.5, p.10579712, 1999. ,
Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy, J Clin Invest, vol.117, issue.5, p.17446932, 2007. ,
Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins, Hum Mol Genet, vol.18, issue.2, p.18927124, 2009. ,
Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation, J Biol Chem, vol.287, issue.48, p.23048029, 2012. ,
Abnormal p38? mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A/C gene mutation, Hum Mol Genet, vol.21, p.22773734, 2012. ,
Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations, Cardiovasc Res, vol.99, issue.3, p.23631840, 2013. ,
Mitogen-activated protein kinase kinase 1/2 inhibition and angiotensin II converting inhibition in mice with cardiomyopathy caused by lamin A/C gene mutation, Biochem Biophys Res Commun, vol.452, issue.4, p.25218145, 2014. ,
Decreased WNT/?-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene, Hum Mol Genet, vol.26, issue.2, p.28069793, 2017. ,
Elevated dual specificity protein phosphatase 4 in cardiomyopathy caused by lamin A/C gene mutation is primarily ERK1/2-dependent and its depletion improves cardiac function and survival, Hum Mol Genet, vol.27, issue.13, p.29668927, 2018. ,
Improvement of left ventricular dysfunction and of survival prognosis of dilated cardiomyopathy by administration of calcium sensitizer SCH00013 in a mouse model, J Am Coll Cardiol, vol.55, issue.14, p.20359603, 2010. ,
Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene, Biochim Biophys Acta, vol.1802, issue.7-8, p.20388542, 2010. ,
Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene. Circulation, vol.123, p.21173351, 2011. ,
Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene, Cardiovasc Res, vol.93, issue.2, p.22068161, 2012. ,
Alteration of performance in a mouse model of Emery-Dreifuss muscular dystrophy caused by A-type lamins gene mutation, Human Molecular Genetics, 2019. ,
Direct interaction between emerin and lamin A, Biochem Biophys Res Commun, vol.267, issue.3, p.10673356, 2000. ,
Interaction between emerin and nuclear lamins, J Biochem, vol.129, issue.2, p.11173535, 2001. ,
Role of A-type lamins in signaling, transcription, and chromatin organization, J Cell Biol, vol.187, issue.7, pp.945-57, 2009. ,
An emerin "proteome": purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture, Biochemistry, vol.46, issue.30, p.17620012, 2007. ,
Multitissular involvement in a family with LMNA and EMD mutations: Role of digenic mechanism?, Neurology, vol.68, issue.22, p.17536044, 2007. ,
Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy, Proc Natl Acad Sci, vol.104, issue.1, p.17182743, 2007. ,
Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle, J Biochem, vol.118, issue.5, p.8749313, 1995. ,
Inhibition of extracellular signal-regulated kinase 1/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation, Skelet Muscle, vol.3, issue.1, p.23815988, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00842001
Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/ utrophin-deficient mice, Skelet Muscle, vol.7, issue.1, p.29078808, 2017. ,
ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene, Hum Mol Genet, vol.25, issue.11, p.27131347, 2016. ,
Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice, J Clin Invest, vol.113, issue.3, p.14755333, 2004. ,
Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic. Front Physiol, vol.9, p.30405424, 2018. ,
Nuclear changes in skeletal muscle extend to satellite cells in autosomal dominant Emery-Dreifuss muscular dystrophy/limb-girdle muscular dystrophy 1B, Neuromuscul Disord, vol.19, issue.1, p.19070492, 2009. ,
Autophagic degradation of nuclear components in mammalian cells, Autophagy, vol.5, issue.6, p.19550147, 2009. ,
Laminopathies": a wide spectrum of human diseases, Exp Cell Res, vol.313, issue.10, p.17467691, 2007. ,
The laminopathies: the functional architecture of the nucleus and its contribution to disease, Annu Rev Genomics Hum Genet, vol.7, p.16824021, 2006. ,
Skeletal Muscle Laminopathies: A Review of Clinical and Molecular Features, Cells, vol.5, issue.3, 2016. ,
Mé jat A. Nuclear envelopathies: a complex LINC between nuclear envelope and pathology, Orphanet J Rare Dis, vol.12, issue.1, p.28854936, 2017. ,
Novel insights into the disease etiology of laminopathies, Rare Dis, vol.1, issue.1, p.24860693, 2013. ,